Get the Stockscreener App
10.80
1.82%
-0.20
Carlsmed Inc stock is traded at $10.80, with a volume of 35,898.
It is down -1.82% in the last 24 hours and down -2.61% over the past month.
Carlsmed Inc is a commercial-stage medical technology company focused on developing AI-enabled personalized solutions for spine surgery. The company operates as a single operating and reportable segment engaged in the design, manufacture, and marketing of its Aprevo technology platform, which provides customized surgical planning and implants for lumbar and cervical spine fusion procedures, mainly sold to hospitals and ambulatory surgical centers.
See More
Previous Close:
$11.00
Open:
$11.056
24h Volume:
35,898
Relative Volume:
0.22
Market Cap:
$293.60M
Revenue:
$56.44M
Net Income/Loss:
$-32.60M
P/E Ratio:
-8.7677
EPS:
-1.2318
Net Cash Flow:
$-35.15M
1W Performance:
-7.38%
1M Performance:
-2.61%
6M Performance:
-18.37%
1Y Performance:
+0.00%
1-Day Range:
$10.79
$11.34
1-Week Range:
$10.70
$11.76
52-Week Range:
$8.50
$17.19
Carlsmed Inc Stock (CARL) Company Profile
Name
Carlsmed Inc
Sector
Industry
Phone
858-295-9290
Address
1800 ASTON AVENUE, CARLSBAD
Compare CARL vs VEEV, BTSG, HQY, TEM, TXG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CARL
Carlsmed Inc
|
10.80 | 293.60M | 56.44M | -32.60M | -35.15M | -1.2318 |
VEEV
Veeva Systems Inc
|
186.24 | 30.25B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
72.91 | 14.31B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
94.64 | 7.91B | 1.34B | 230.70M | 440.96M | 2.6695 |
TEM
Tempus Ai Inc
|
42.69 | 7.69B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
46.27 | 5.87B | 638.78M | -22.66M | 122.18M | -0.1744 |
Carlsmed Inc Stock (CARL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-18-25 | Initiated | BTIG Research | Buy |
| Aug-18-25 | Initiated | BofA Securities | Buy |
| Aug-18-25 | Initiated | Goldman | Buy |
| Aug-18-25 | Initiated | Piper Sandler | Overweight |
| Aug-18-25 | Initiated | Truist | Buy |
Carlsmed Inc Stock (CARL) Latest News
KCM Capital Inc Invests $1.81 Million in Carlsmed, Inc. $CARL - MarketBeat
Carlsmed to report Q2FY26 results on August 5, 2026 - scanx.trade
Carlsmed Inc. to Report Second Quarter 2026 Financial Results on August 5, 2026 - marketscreener.com
Wall Street analysts think Carlsmed, Inc. (CARL) could surge 90.77%: Read this before placing a bet - MSN
Possible Turnaround For Carlsmed Insiders, Still Down US$1.7m - 富途牛牛
Gross profit of Carlsmed, Inc. – LS:A41CM7 - TradingView
CARL Initiates Coverage On Needham -- Rating Set to Buy - GuruFocus
Needham initiates Carlsmed stock with buy rating on implant differentiation By Investing.com - Investing.com Nigeria
Needham initiates Carlsmed stock with buy rating on implant differentiation - Investing.com
Needham Initiates Carlsmed(CARL.US) With Buy Rating, Announces Target Price $17 - Moomoo
CARL Forecast — Price Target — Prediction for 2027 - TradingView
Carlsmed, Inc. Actuals & Estimates (NASDAQ:CARL) - TradingView
Carlsmed, Inc. Actuals & Estimates (DUS:I82) - TradingView
Price to sales forward of Carlsmed, Inc. – NASDAQ:CARL - TradingView
CARL Q1 2026 Earnings: Bottom-Line Beat Lifts SentimentGuidance vs Actual - DonanımHaber
Enterprise value to revenue forward of Carlsmed, Inc. – NASDAQ:CARL - TradingView
CARL Q1 2026 Earnings: Narrower Loss Beats Estimates as Clinical Progress ContinuesPre-Announcement Alert - dars.gov.et
I82 Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to EBITDA forward of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Enterprise value to revenue forward of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Carlsmed, Inc. Actuals & Estimates (LSX:A41CM7) - TradingView
A41CM7 Forecast — Price Target — Prediction for 2027 - TradingView
Price to earnings forward of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Price to book forward of Carlsmed, Inc. – NASDAQ:CARL - TradingView
Price to sales forward of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Carlsmed Inc. (CARL) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
BTIG Maintains Carlsmed(CARL.US) With Buy Rating, Maintains Target Price $23 - Moomoo
Form 4 Carlsmed Inc For: 22 June By Investing.com - Investing.com Nigeria
[Form 4] CARLSMED, INC. Insider Trading Activity - Stock Titan
CARL Q1 2026 Earnings: EPS Beats Estimates as Pre-Revenue Company Focuses on Personalized Spine ExpansionSpecial Dividend Alert - dars.gov.et
Carlsmed Ord Shs (CARL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CARL: AI-driven personalized surgery platform accelerates growth and efficiency, outpacing traditional models - TradingView
CARLSMED INC (CARL) Stock Chart - ChartMill
CARL Q1 2026 Earnings: Narrower-than-Expected Loss as Development Progress ContinuesPeak Earnings Alert - newsline.com
Carlsmed Shareholders Back Directors and Auditor at Meeting - TipRanks
Carlsmed Stock Faces A Crucial Week After Friday’s Drop - Bez Kabli
Carlsmed, Inc. Cash Flow – LSX:A41CM7 - TradingView
CARL Q1 2026 Earnings: Personal Surgery Specialist Beats EPS Estimates; Stock RisesEarnings Surprise Score - The Legal Advocate
CARLCarlsmed Inc Stock Price and Quote - Finviz
Wall Street analysts see a 51.94% upside in Carlsmed, Inc. (CARL): Can the stock really move this high? - MSN
Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High? - sharewise.com
Basic earnings per share (basic EPS) of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Carlsmed (CARL) Stock: Jumps +3.57%, Approaching $11.89 2026-05-19Free Signal Network - Newser
Carlsmed (CARL) Down -1.66% — How Low Could It Go? 2026-05-14Earnings Breakout - newser.com
Price to cash flow ratio of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Return on equity % of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Total equity of Carlsmed, Inc. – LSX:A41CM7 - TradingView
Carlsmed, Inc. Income Statement – LSX:A41CM7 - TradingView
Carlsmed raises FY 2026 revenue outlook to $72M-$77M as CMS proposes new MS-DRGs for Aprevo lumbar - MSN
Top Carlsmed (CARL) Competitors 2026 - MarketBeat
Carlsmed Inc Stock (CARL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Carlsmed Inc Stock (CARL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Cordonnier Michael | CEO, President |
Mar 02 '26 |
Option Exercise |
0.34 |
197,855 |
66,281 |
1,554,501 |
| Cordonnier Michael | CEO, President |
Mar 02 '26 |
Sale |
13.29 |
197,855 |
2,629,889 |
1,356,646 |
1.99%
2.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):